Holen Sie sich die Stockscreener-App
95.47
0.19%
-0.18
Handel nachbörslich:
96.00
0.53
+0.56%
Schlusskurs vom Vortag:
$95.65
Offen:
$94.88
24-Stunden-Volumen:
782.87K
Relative Volume:
0.53
Marktkapitalisierung:
$2.77B
Einnahmen:
$861.31M
Nettoeinkommen (Verlust:
$53.12M
KGV:
55.31
EPS:
1.7262
Netto-Cashflow:
$85.01M
1W Leistung:
-1.11%
1M Leistung:
-25.02%
6M Leistung:
-26.40%
1J Leistung:
-49.51%
1-Tages-Spanne:
$93.69
$95.75
1-Wochen-Bereich:
$93.05
$101.59
52-Wochen-Spanne:
$70.77
$216.01
Inspire Medical Systems Inc Stock (INSP) Company Profile
Firmenname
Inspire Medical Systems Inc
Sektor
Branche
Telefon
763-957-5037
Adresse
5500 WAYZATA BLVD, GOLDEN VALLEY
Vergleichen Sie INSP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
95.47 | 2.78B | 861.31M | 53.12M | 85.01M | 1.7262 |
|
ABT
Abbott Laboratories
|
124.84 | 217.03B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.06 | 142.51B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.22 | 135.66B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.52 | 124.70B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.85 | 50.07B | 5.88B | 1.34B | 799.60M | 2.3489 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-12-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | Hochstufung | Truist | Hold → Buy |
| 2025-11-25 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | Hochstufung | Stifel | Hold → Buy |
| 2025-11-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2025-09-02 | Eingeleitet | Evercore ISI | Outperform |
| 2025-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | Herabstufung | Truist | Buy → Hold |
| 2024-11-20 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-05-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-04-19 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-03-19 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2024-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-14 | Eingeleitet | Mizuho | Buy |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-12-13 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-11-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-11-03 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2020-09-22 | Eingeleitet | JP Morgan | Overweight |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-15 | Eingeleitet | Goldman | Buy |
| 2020-06-18 | Bestätigt | Piper Sandler | Overweight |
| 2020-05-18 | Eingeleitet | Lake Street | Buy |
| 2020-04-28 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-28 | Eingeleitet | Oppenheimer | Underperform |
| 2020-01-27 | Eingeleitet | Oppenheimer | Underperform |
| 2019-11-06 | Hochstufung | Berenberg | Sell → Hold |
| 2019-02-05 | Eingeleitet | Dougherty & Company | Buy |
| 2018-11-28 | Eingeleitet | Berenberg | Sell |
| 2018-10-29 | Eingeleitet | Leerink Partners | Outperform |
| 2018-05-29 | Eingeleitet | Guggenheim | Buy |
| 2018-05-29 | Eingeleitet | Stifel | Buy |
| 2018-05-29 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Inspire Medical Systems Inc Aktie (INSP) Neueste Nachrichten
INSP STOCK NOTICE: Inspire Medical Systems, Inc. Inspire V Delays Lead to Securities Class Action – Contact BFA Law before January 5 Legal Deadline - GlobeNewswire Inc.
Inspire Medical Systems, Inc. Class Action: Levi & Korsinsky Reminds Inspire Medical ... - Bluefield Daily Telegraph
Inspire Medical Systems, Inc. Class Action: Levi & - GlobeNewswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems - GlobeNewswire
INSP Investors Have Opportunity to Lead Inspire Medical - GlobeNewswire
INSP DEADLINE NOTICE: ROSEN, NATIONAL INVESTOR COUNSEL, - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Inspire Medical - GlobeNewswire
INSP INVESTOR LOSSES: Inspire Medical Systems, Inc. - GlobeNewswire
INSP DEADLINE: Faruqi & Faruqi Reminds Inspire Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026 - TMX Newsfile
2025-12-24 | INSP LAWSUIT ALERT: Levi & Korsinsky Notifies Inspire Medical Systems, Inc. InvestorsLead Plaintiff Deadline January 5, 2026 | NYSE:INSP | Press Release - Stockhouse
Securities Lawsuit Alert: Inspire Medical Systems, Inc. (INSP) InvestorsContact Levi & Korsinsky Before January 5, 2026 - ACCESS Newswire
Shareholders of Inspire Medical Systems, Inc. (INSP): Protect Your Rights Before January 5, 2026Contact Levi & Korsinsky - ACCESS Newswire
Did You Lose Money on Inspire Medical Systems, Inc. (INSP)? Levi & Korsinsky Urges Investors to Act Before January 5, 2026 - ACCESS Newswire
INSP INVESTOR ALERT: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut - PR Newswire
Class Action Filed Against Inspire Medical Systems, Inc. (INSP) - GuruFocus
Class Action Lawsuit Filed: Inspire Medical Systems, Inc. (INSP)Join by January 5, 2026Contact Levi & Korsinsky - ACCESS Newswire
Class Action Filed Against Inspire Medical Systems, Inc. (INSP) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
INSP DEADLINE ALERT: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut - GlobeNewswire Inc.
UBS Maintains Inspire Medical Systems (INSP) Neutral Recommendation - Nasdaq
Shareholders SueWallSt in New Class Action Against Inspire Medical Systems, Inc.Act Now (2025-12-23) - Seeking Alpha
Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - GuruFocus
INSP: UBS Raises Price Target for Inspire Medical Systems | INSP Stock News - GuruFocus
Inspire Medical Systems (NYSE:INSP) Shares Down 3.9%Here's What Happened - MarketBeat
Important Notice to Long-Term Shareholders of Alexandria - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Inspire Medical Systems Investors Have Opportunity to Lead Class Action Lawsuit - Morningstar
Inspire Medical Systems (INSP) Facing Lawsuit Over Sleep Apnea Treatment Claims - TipRanks
Your Guide to the Inspire Medical Systems, Inc. LawsuitA SueWallSt Podcast From Levi & Korsinsky - ACCESS Newswire
Class Action Filed Against Inspire Medical Systems, Inc. (INSP) Seeking Recovery for InvestorsContact Levi & Korsinsky - Morningstar
Congress Asset Management Co. Has $1 Million Stock Holdings in Inspire Medical Systems, Inc. $INSP - MarketBeat
January 5, 2026 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against INSP - Sahm
INSP DEADLINE NOTICE: ROSEN, REGARDED INVESTOR COUNSEL, - GlobeNewswire
Why Inspire Medical Systems Shares Are Under Pressure - TipRanks
INSP STOCK: Inspire Medical Systems, Inc. Product Delays Trigger Securities Fraud Class ActionContact BFA Law by January 5 Court Deadline - ACCESS Newswire
Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against Inspire Medical Systems, Inc. - FinancialContent
The Gross Law Firm Reminds Inspire Medical Systems, Inc. - GlobeNewswire
Deadline Alert: Inspire Medical Systems, Inc. (INSP) - GlobeNewswire
Inspire Medical Systems Inc Stock Analysis and ForecastTechnology Stock Trends & Investment Recommendations You Can Trust - earlytimes.in
MAC attack on CPT code for hypoglossal nerve stimulation dings Inspire - BioWorld MedTech
Here's Why You Should Retain INSP Stock in Your Portfolio Now - Finviz
2025-12-22 | INSP SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Inspire Medical Systems, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! | NYSE:INSP | Press Release - Stockhouse
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Securities Lawsuit Alert: Inspire Medical Systems, Inc. (INSP)Contact Levi & Korsinsky Before January 5, 2026 - ACCESS Newswire
2025-12-21 | Securities Fraud Class Action Filed Against Inspire Medical Systems, Inc. (INSP)Levi & Korsinsky Reminds Investors of January 5, 2026 | NYSE:INSP | Press Release - Stockhouse
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potent - GuruFocus
Inspire Medical Systems (INSP) Price Target Increased by 12.65% to 144.32 - Nasdaq
Inspire Medical slides after Medicare reimbursement policy change - MSN
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Inspire Medical Systems - Eagle-Tribune
Lost Money on Inspire Medical Systems, Inc. (INSP)? Join Class Action Before January 5, 2026Contact Levi & Korsinsky - ACCESS Newswire
INSP COURT REMINDER: Inspire Medical Systems, Inc. Securities Fraud Deadline Approaching – Contact BFA Law before January 5 - GlobeNewswire
2025-12-20 | Lost Money on Inspire Medical Systems, Inc. (INSP)? Join Class Action Before January 5, 2026Contact Levi & Korsinsky | NYSE:INSP | Press Release - Stockhouse
Is Inspire Medical Systems Inc. stock resilient to inflationRisk Management & Stepwise Swing Trade Plans - Bölüm Sonu Canavarı
Finanzdaten der Inspire Medical Systems Inc-Aktie (INSP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.07%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):